Health

Joseph Stiglitz, Michael Spence and a global team of leading thinkers are calling for new thinking & new rules for the world economy

Increased financialization is driving healthcare costs and must be addressed in our nation’s public policy.

IMPORTANT: Due to growing concerns around the coronavirus, the INET Conference, as well as these workshops will be postponed. Applicants will soon be provided further information.

Technology has played a central role in the response to the COVID-19 pandemic. But that has come with increased risks to privacy. How do we balance our needs for safety, convenience and privacy in the wake of this crisis?

The economic and social costs of the global lockdown have been astronomical but as governments look to begin the process of reopening economies it will be critical to develop strategies that balance both the health and economic risks of the pandemic.

As protests erupt on the streets of America and the world, current power structures no longer feel tenable. Can this popular uprising break the neoliberal grip on the state and create lasting structural change that will empower the disenfranchised?

The COVID-19 pandemic has thrust us into a new reality, and any course we set now will have huge and lasting repercussions on public health and the economy.

Developing countries, many of which appear not to have felt the health effects of COVID to the same extent as Europe and the US, are nonetheless facing severe economic effects as the pandemic pushes the global economy into a recession.

In March the US government authorized the largest domestic bailout in history. Who were the real winners and losers of this bailout? Pulitzer Prize winning reporter Jesse Eisinger has been following the money.

As the world economy seeks to emerge from the deep recession caused by the pandemic, economic nationalism and isolationism are on the rise. Yet the better response to lower growth and worsening inequality could involve globally-coordinated policy responses that focus on broad based, sustainable economic growth. Now more than ever it is time for a new global economic policy paradigm that can facilitate a strong recovery.

While policymakers around the world are in fire-fighting mode, trying to keep the economies in their charge running and the mysterious pandemic under control, the global terrain beneath our feet is shifting. Which countries will emerge as winners and losers in the new global landscape?

The rise of the Knowledge Based Economy and subsequent Data Driven Economy has created a new world in which the basis of wealth and power is derived from control of these intangible assets, alongside creating a new kind of social and political space in which both our public and private spheres are technologically reshaped. The COVID-19 pandemic has accelerated these transformations that permeate our world and has amplified their effects.

Stigmatizing and relegating an activity to the shadows doesn’t improve anyone’s welfare

Greg Mankiw says there should be a market for kidneys, but not for paying drug addicts to get sterilized.

Economic distress in rural areas and opioid exposure in cities are key indicators of overdose deaths

A better set of approaches for the 21st century.

Price gouging in the US pharmaceutical drug industry goes back more than three decades.

New research points to critical role of public funding in drug discoveries and development for the last decade

Private equity firms have become major players in the healthcare industry. How has this happened and what are the results?

This paper considers the relationship between profits realized from higher insulin list prices, pharmaceutical innovation, and the financial structures of the three dominant insulin manufacturing companies, which set list prices.

As Covid-19 spreads globally in the first quarter of 2020, this paper finds that firms’ primary concerns relate to the collapse of demand, increased uncertainty, and disruption in supply chains

The success of projects for pandemic preparedness and response depends on the strength of government-business collaborations.

Amid debates over costs—and profits—from a coronavirus vaccine, a new study shows that taxpayers have been footing the bill for every new drug approved between 2010 and 2019

How Investor-owned Physician Practices Are Driving up Healthcare Costs

There is not one opioid crisis in America—there are many. And supply-focused measures won’t stop them.

Pharmaceutical pushers like Purdue “couldn’t have done their dirty work” without America’s increasingly unbalanced economy

Cuba’s entirely state-owned biopharmaceutical industry has been remarkably successful, and can serve as a model for other nations

From the Rust Belt to Rural America, Economic and Social Distress Helped Shape the 2016 US Presidential Election Outcome

Once again, an out-of-control industry is threatening public health on a mammoth scale

Greater efficiency, lower costs, and universal coverage make it the sustainable option, say some top economists

A call to action for a world economy in crisis

Evidence shows pharmaceutical companies won’t stop price-gouging and risking American lives for financial gain in this time of crises – unless we force them.

With the COVID-19 death toll rising, we should question the wisdom and morality of an IP system that silently condemns millions of human beings to suffering and death every year.

Researchers have shown that the financial and economic impacts of denying women abortion care can last years

John Ruskin helps shed light on what it means to have an economy that demands we die for it

The world is on edge at the prospect of a resurgent wave of infections. Models and speculation are rife, but facts remain scarce, which is why the events in Wisconsin on April 7, and their eventual impact, are so important.

An interview with Pr Benno Ndulu, the former Governor of the Bank of Tanzania, for INET’s series on COVID-19 and Africa

An introduction to a series of interviews conducted by Dr. Dr. Folashadé Soulé and Dr. Camilla Toulmin in support of INET’s Commission on Global Economic Transformation (CGET)

An interview with Dr Fatima Denton, Director of the United Nations University – Institute for Natural Resources in Africa, for INET’s series on COVID-19 and Africa

An interview with Professor Felwine Sarr, Professor of Economics at the Université Gaston Berger of Saint-Louis in Senegal, for INET’s series on COVID-19 and Africa

Entretien avec Pr Felwine Sarr, Professeur Titulaire des Universités et agrégé en économie à l’Université Gaston Berger de Saint-Louis au Sénégal, pour la série d’INET sur COVID-19 et l’Afrique

In this conversation with Folashadé Soulé and Camilla Toulmin, Pr Takyiwaa Manuh analyses how the pandemic has disproportionately affected women at different levels especially in Ghana, and describes why governments need to focus more strongly on the gendered impacts of COVID-19 in both their sanitary and economic response.

Gilead’s shareholders want exorbitant profits from Remdesivir, even though it was the public that enabled its development.

In this conversation with Folashadé Soulé and Camilla Toulmin, Pr Njuguna Ndung’u, a Kenyan economist, Director of the African Economic Research Consortium (AERC), a pan-African organization devoted to the advancement of economic policy research and training in sub-Saharan Africa, and former Governor of the Central Bank of Kenya (2007-2015) analyses how the pandemic creates more fragility in African economies, but also how reforms could be implemented during this crisis; and the urgent need for investment in strong health institutional capacities

When people recognize just how dangerous covid is, they worry more about the economy

Chioma Agwuegbo of TechHer Nigeria, talks to Folashadé Soulé and Herbert Mba Aki about how the pandemic is impacting young people in Nigeria, especially young women, and how African youth are tackling the crisis.

Dans le cadre de cet entretien, Pr Kako Nubukpo, Doyen de la Faculté des Sciences Economiques et de Gestion (FASEG) de l’Université de Lomé au Togo, et ancien Ministre de la Prospective et de l’Evaluation des politiques publiques du Togo, revient sur l’impact économique et social de la crise du COVID-19 au Togo et sur ses répercussions sur les politiques économiques dont les réformes monétaires et fiscales en cours en Afrique de l’Ouest et Centrale.

During this interview, Professor Kako Nubukpo, Dean of the Faculty of Economics at the University of Lomé, Togo and former Minister of Prospective and Evaluation of Public Policy of Togo considers the economic and social impact of the COVID-19 crisis and its repercussions on monetary policy and fiscal reforms underway in West and Central Africa today.

As we face a coronavirus-induced health and economic crisis of uncertain duration, policy makers should be particularly concerned about private equity’s heightened use of debt to buy out healthcare providers and take them private, with no regulatory oversight.

The scale of firm exposure to the coronavirus is unprecedented by earlier outbreaks, spans all major economies and is pervasive across all industries

Contrary to pharmaceutical company claims, revenue from high insulin prices are going to shareholders, not R&D

Amid debates over costs—and profits—from a coronavirus vaccine, a new study shows that taxpayers have been footing the bill for every new drug approved between 2010 and 2019

Dr. Ming Lin spoke out about Covid safety at his hospital and was fired. He’s fighting back against a system that put profits over human life.